Concurrently, the probe's lead developer is promoted to chief technology officer.
Endomagnetics, a company developing a portfolio of products aiming to improve the standard of cancer care, has developed higher performance probe for its SentiMag instrument. Endomagnetics is a University College London (UCL) spin-out, based on research at UCL and Houston University, and is based in Silicon Fen, the tech cluster in Cambridge.
The SentiMag probe, together with the company’s Sienna tracer, can locate lymph nodes as part of cancer staging procedures, particularly in breast cancer. The system has been validated…
